Search for: "OTSUKA AMERICA PHARMACEUTICAL INC" Results 1 - 10 of 10
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2015, 7:16 pm by FDABlog HPM
Those are the two core questions posed in a lawsuit Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc., and Otsuka America Pharmaceutical, Inc. [read post]
30 Jan 2013, 11:02 am
Last week, the FDA issued a warning of potential risk of liver injury from Samsca (tolvaptan) manufactured by Otsuka America Pharmaceutical Inc. [read post]
7 May 2013, 8:22 am by Derek T. Braslow
The initial letter to health care providers from the manufacturer, Otsuka America Pharmaceutical, Inc., was sent January 22, 2013, followed by an FDA Safety Alert on January 25, 2013. [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Bristol-Meyers Squibb Co. and Otsuka America Pharmaceutical, Inc., No. 12-cv-01124 (E.D.N.Y., Mar. 7, 2012) (Complaint) [read post]
21 Aug 2017, 12:23 pm by Altman & Altman
And that’s not all; Otsuka America Pharmaceutical, Inc. [read post]
26 Jun 2013, 7:51 pm by FDABlog HPM
Court dismisses with prejudice two of the three alleged RICO theories Plaintiffs alleged that the co-pay savings program, offered jointly by the defendants, Bristol-Myers Squibb and Otsuka America Pharmaceutical, Inc., constitutes substantive RICO violations and a conspiracy to violate RICO. [read post]